Amvuttra (Vutrisiran)

Overview
Amvuttra is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with hereditary transthyretin-mediated (hATTR) amyloidosis who have polyneuropathy (nerve damage). Amvuttra…

Attruby (Acoramidis)

Overview
Attruby is approved by the U.S. Food and Drug Administration (FDA) for the treatment of cardiomyopathy (disorder of the heart muscle) caused by wild-type or variant transthyretin-mediated amyloidosis (ATTR-CM) in…

Darzalex Faspro (Daratumumab and Hyaluronidase-Fihj)

Overview

Darzalex Faspro is approved by the U.S. Food and Drug Administration (FDA) for the treatment of newly diagnosed light chain (AL) amyloidosis in adults. This approval is under the FDA’s accelerated approval…